@article {3113,
	title = {CCL3L1 copy number is a strong genetic determinant of HIV seropositivity in Caucasian intravenous drug users.},
	journal = {The Journal of infectious diseases},
	volume = {201},
	year = {2010},
	month = {2010 Mar},
	pages = {730-9},
	abstract = {A high copy number of CCL3L1, the most potent human immunodeficiency virus (HIV)-suppressive chemokine, associates with reduced HIV susceptibility. Whether CCL3L1 influences acquisition of multiple blood-borne infections (eg, hepatitis C virus [HCV], HIV, and hepatitis B virus [HBV] infections), which occur commonly among injection drug users (IDUs), is unknown.},
	keywords = {Adult, Chemokines, CC, Drug Users, Estonia, European Continental Ancestry Group, Female, Gene Dosage, Hepacivirus, Hepatitis C, HIV Seropositivity, Humans, Immunity, Innate, Male, Polymerase Chain Reaction, Substance Abuse, Intravenous},
	issn = {1537-6613},
	doi = {10.1007/s10461-009-9532-3},
	author = {Huik, Kristi and Sadam, Maarja and Karki, T{\~o}nis and Avi, Radko and Krispin, T{\~o}nu and Paap, Piret and R{\"u}{\"u}tel, Kristi and Uusk{\"u}la, Anneli and Talu, Ave and Abel-Ollo, Katri and Lutsar, Irja}
}
